Management of Beta-Blocker-Induced Nightmares

Understanding and Recommendations

The American Geriatrics Society recognizes sleep disturbances, including nightmares and night terrors, as adverse effects of beta-blockers, particularly lipophilic agents like metoprolol 1
Switching to a hydrophilic beta-blocker such as atenolol is recommended as the most effective solution for patients experiencing metoprolol-induced nightmares, according to the American College of Cardiology 2

Hydrophilic beta-blockers, which do not readily cross the blood-brain barrier, are alternatives for patients experiencing unpleasant dreaming, as suggested by the American Heart Association 2
Nebivolol may be considered for migraine prevention with possibly fewer CNS side effects, as noted by the American College of Cardiology 3

Consider changing the timing of metoprolol administration or dose reduction as alternative management options before switching medications, as recommended by the American Academy of Pediatrics 4
For persistent nightmares despite beta-blocker changes, consider adjunctive treatment with prazosin, which is specifically recommended for treatment of PTSD-associated nightmares and may help with beta-blocker-induced nightmares, according to the American Academy of Sleep Medicine 5, 6
Alternative medications for nightmare treatment include clonidine or trazodone, as suggested by the American Academy of Sleep Medicine 7, 8

Monitor for potential orthostatic hypotension when using prazosin or clonidine as adjunctive treatments, as cautioned by the American Academy of Sleep Medicine 5, 7
Be aware that hydrophilic beta-blockers like atenolol may have different pharmacokinetic profiles requiring dosage adjustments, as noted by the American College of Cardiology 2

Nonselective beta-blockers, like propranolol, are typically indicated for anxiety, psychiatric disorders, and endocrine diseases, according to the American Heart Association 9, 10, 11
Beta-selective agents are preferred for cardiovascular diseases, as recommended by the American College of Cardiology 9, 10, 11
When nightmares occur with nonselective agents used for anxiety, the underlying anxiety disorder itself may contribute to nightmares, requiring reassessment of the treatment approach, as suggested by the American Psychiatric Association 9, 10, 11

Prazosin is the only medication with Level A evidence for nightmare treatment, starting at 1 mg at bedtime and titrating by 1-2 mg every few days to an average effective dose of 3 mg, as recommended by the American Academy of Sleep Medicine 9